A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is
The results of basic clinical randomized trials of hypofractionated (HF) radiotherapy (R T) regimens used after organ-sparing su rgery for Stages I-IIa breast cancer (BC) were analyzed. The HF adjuvant RT regimens were shown to be safe and an alternative to the standard RT in patients with BC after organ-saving operations.doi:10.17650/1994-4098-2011-0-3-45-53 doaj:b3f7454a53e54e608db9b4af1c0c98b0 fatcat:idjocznzp5aatchmaoxfcvniki